Fact CheckerSign in

NCT01004952Completed

Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection

Measuring Real Time Decision-Making About UVR Protection

Source: ClinicalTrials.gov · Last updated 7 Jan 2026

Brief summary (registry, in English)

The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk factor for melanoma. The investigators would like to understand the decisions people make about sun protection so that they can improve their ability to help individuals who may be at risk for melanoma.

Status (registry)
Completed
Study type
Observational
Enrollment
94 (actual)
First submitted
29 Oct 2009
Start date
27 Oct 2009
Primary completion date
6 Sept 2024
Lead sponsor
Memorial Sloan Kettering Cancer Center
Diseases
Melanoma
NCT number
NCT01004952

What you commit to

  • Study type: Observational
  • Participants enrolled: 94
  • From 27 Oct 2009 to the primary completion date, 6 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • First-degree relatives of melanoma patients who report never using UVR protection;
  • Patient's who provide consent for Phase I will not be eligible for Phase II.
  • Any first-degree relative of a melanoma patient who already has a first-degree relative who consented to the study;
  • Unable to provide informed consent.

Who the study is looking for

  • A first-degree biological relative (a child, sibling or parent) as per self report of an MSKCC follow-up surgical patient diagnosed with melanoma as per pathology report or clinician's judgment;
  • English-fluent; the surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.
  • 18 years of age or older;
  • For Phase I only: FDRs who live within a 50 mile radius of MSKCC to make it feasible for Ms. Shuk to be able to arrive at each person's home for the in-home interview without the cost being prohibitive;
  • For Phase I only: Can recall a period when s/he was out in the sun for at least one hour on a sunny day this past summer 2009.
  • For Phase I only: Can recall a separate period when s/he was out in the sun for at least one hour on a sunny day this past summer 2009, but s/he was in a different location from the period referenced above.
  • For Phase II only: FDRs who self-report at least 1 consecutive hour in the morning (dawn to 12:30pm) and 1 consecutive hour in the afternoon (12:30-5pm) of daily (weekend and weekday) outdoor activities on the screening questionnaire

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan-Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.